INS and type 2 diabetes mellitus: Previous studies have concentrated on the insulin mimetic properties of visfatin, due to the original work by Fukuhara and co-workers, with subsequent human studies noting increased circulating visfatin concentration in states of hyperglycemia and T2DM, which reduced with insulin treatment [3]–[6].